1-13 of 13
Paige Baldwin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB105: In vivo CAR T therapy: targeted in vivo gene delivery of a CAR using a CD8-specific fusogen results in tumor eradication

Akinola Emmanuel, Patty Cruite, Hanane Ennajdaoui, Carmela Passaro, Paige Baldwin, Victoria Duback, Anna Liang, Jess Elman, Samantha Crocker, Shirisha Amatya, Caspian Harding, Allyse Mazarelli, Sergey Lyubinetsky, Vidur Patel, Avani Parikh, Kelan Hlavaty, Jason Rodriguez, Lauren Pepper, Albert Ruzo, Salvatore Iovino, Kutlu Elpek, Michael Laska, Trevor McGill, Donna Dambach, Terry Fry, Jagesh Shah
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB105.
DOI: https://doi.org/10.1158/1538-7445.AM2021-LB105
Published: 01 July 2021
View article
Journal Articles

Abstract 3642: Combination nanotherapy using the PARP inhibitor talazoparib and cyclin dependent kinase inhibitor dinaciclib

Paige Baldwin, Adrienne Orriols, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3642.
DOI: https://doi.org/10.1158/1538-7445.AM2019-3642
Published: 01 July 2019
View article
Journal Articles

Abstract 3874: Developing a nanoformulation of the PARP inhibitor talazoparib as a novel delivery for treatment of BRCA-deficient breast cancer

Di Zhang, Paige Baldwin, Srinivas Sridhar, Karen Liby
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3874.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3874
Published: 01 July 2018
View article
Journal Articles

Abstract 3710: Nanoparticle-mediated concomitant radiation dose amplification and PARP inhibition in lung cancer

Ana G. Vazquez-Pagan, Paige Baldwin, Ravina M. Ashtaputre, Sijumon Kunjachan, Srinivas Sridhar, Rajiv Kumar, Ross Berbeco
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3710.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3710
Published: 01 July 2018
View article
Journal Articles

Abstract 3715: Targeted nanotherapy using the PARP inhibitor talazoparib for breast cancer treatment

Paige Baldwin, Rajiv Kumar, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3715.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3715
Published: 01 July 2018
View article
Journal Articles

Abstract 3100: Nanoformulated Talazoparib and Olaparib for enhanced delivery

Paige Baldwin, Rajiv Kumar, Edward Favours, Karen Liby, Raushan Kurmasheva, David Kozono, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3100.
DOI: https://doi.org/10.1158/1538-7445.AM2017-3100
Published: 01 July 2017
View article
Journal Articles

Abstract 5054: Nanoformulation of talazoparib to increase efficacy when combined with temozolomide for the treatment of Ewing sarcoma xenografts

Nabeela Baig, Rostislav Likhotvorik, Paige Baldwin, Srinivas Sridhar, Raushan Kurmasheva
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5054.
DOI: https://doi.org/10.1158/1538-7445.AM2017-5054
Published: 01 July 2017
View article
Journal Articles

Abstract B30: Sustained release of PARP inhibitor Talazoparib and chemotherapeutic Docetaxel from modified brachytherapy spacers for treatment of breast and prostate cancer

Jodi Belz, Noelle Castilla Ojo, Paige Baldwin, Rajiv Kumar, Anne van de Ven, Karen Liby, Robert Cormack, Mike Makrigiorgos, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2017) 77 (2_Supplement): B30.
DOI: https://doi.org/10.1158/1538-7445.EPSO16-B30
Published: 16 January 2017
View article
Journal Articles

Abstract B29: Nanoformulations and sustained delivery systems for the PARP inhibitors Olaparib and Talazoparib

Paige Baldwin, Anders Ohman, Jodi Belz, Jeremy Thong, Noelle Castilla Ojo, Karen Liby, Daniela Dinulescu, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2017) 77 (2_Supplement): B29.
DOI: https://doi.org/10.1158/1538-7445.EPSO16-B29
Published: 16 January 2017
View article
Journal Articles

Abstract B48: Prostate cancer pre-treatment with nanoformulated Olaparib overcomes radiation resistance

Anne L. van de Ven, Shifalika Tangutoori, Paige Baldwin, Ju Qiao, Codi Gharagouzloo, Nina Seitzer, John Clohessy, Houari Korideck, G. Mike Makrigiorgos, Robert Cormack, Pier Paolo Pandolfi, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2017) 77 (2_Supplement): B48.
DOI: https://doi.org/10.1158/1538-7445.EPSO16-B48
Published: 16 January 2017
View article
Journal Articles

Abstract 4335: Nanoformulations of PARP inhibitors Olaparib and Talazoparib for targeted cancer therapy

Paige Baldwin, Anders Ohman, Jeremy Thong, Shifalika Tangutoori, Anne van de Ven, Rajiv Kumar, Daniela Dinulescu, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4335.
DOI: https://doi.org/10.1158/1538-7445.AM2016-4335
Published: 15 July 2016
View article
Journal Articles

Abstract 3900: Sustained release of PARP inhibitor Talazoparib and chemotherapeutics from biodegradable implants for treatment of breast and prostate cancer

Jodi Belz, Noelle Castilla Ojo, Paige Baldwin, Rajiv Kumar, Anne van de Ven, Karen Liby, Robert Cormack, Mike Makrigiorgos, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3900.
DOI: https://doi.org/10.1158/1538-7445.AM2016-3900
Published: 15 July 2016
View article
Journal Articles

Abstract 2397: Nanoformulations of PARP inhibtors for cancer therapy

Shifalika Tangutoori, Paige Baldwin, Houari Korideck, Robert Cormack, Mike G. Makrigiorgos, Srinivas Sridhar
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2397.
DOI: https://doi.org/10.1158/1538-7445.AM2014-2397
Published: 01 October 2014
View article